Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session - Thoracic cancers

Updated overall survival (OS) from extended follow up in ARCHER 1050: A randomized phase III study comparing dacomitinib with gefitinib as first-line therapy for patients (pts) with EGFR mutations

Date

23 Nov 2019

Session

Mini Oral session - Thoracic cancers

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Tony S.K. Mok

Citation

Annals of Oncology (2019) 30 (suppl_9): ix183-ix202. 10.1093/annonc/mdz446

Authors

T.S.K. Mok1, Y. Cheng2, X. Zhou3, K.H. Lee4, K. Nakagawa5, S. Niho6, R. Linke7, R. Rosell8, J. Corral9, M.R. Migliorino10, A. Pluzanski11, K. Noonan12, Y. Tang13, K.D. Wilner13, Y. Wu14

Author affiliations

  • 1 State Key Laboratory Of South China, Department Of Clinical Oncology, Chinese University of Hong Kong, N/A - Hong Kong/CN
  • 2 N/a, Jilin Provincial Cancer Hospital, Changchun/CN
  • 3 Department Of Respiratory Medicine, First Affiliated Hospital of Third Military Medical University, Chongqing/CN
  • 4 Chungbuk National University College Of Medicine, Chungbuk National University Hospital, Cheongju/KR
  • 5 N/a, Kindai University Hospital, Osaka/JP
  • 6 Department Of Thoracic Oncology, National Cancer Center Hospital East, 277-8577 - Kashiwa/JP
  • 7 N/a, SFJ Pharmaceuticals®, Pleasanton/US
  • 8 N/a, Catalan Institute of Oncology, Barcelona/ES
  • 9 N/a, Hospital Universitario Virgen del Rocio, Seville/ES
  • 10 Pulmonary Oncology Unit, San Camillo-Forlanini Hospital, Rome/IT
  • 11 N/a, The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw/PL
  • 12 N/a, Pfizer Inc., Groton/US
  • 13 N/a, Pfizer Oncology, La Jolla/US
  • 14 Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.